Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.74 USD | +0.65% | +15.64% | +45.10% |
10/04 | Transcript : Chemomab Therapeutics Ltd. - Special Call | |
07/03 | Chemomab Therapeutics Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Chemomab Therapeutics Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Chemomab Therapeutics Ltd.
Roth MKM | |
Oppenheimer | |
Aegis Capital | |
Cantor Fitzgerald |
EPS Revisions
- Stock Market
- Equities
- CMMB Stock
- Consensus Chemomab Therapeutics Ltd.